You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ovarian cancer, pembrolizumab, olaparib

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Gastric Adenocarcinoma Trial in Baltimore (Paclitaxel, Olaparib, Pembrolizumab)

Recruiting
  • Advanced Gastric Adenocarcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 3, 2022

Glioblastoma, Recurrent Glioblastoma Trial in Boston (Pembrolizumab, Olaparib, Temozolomide)

Not yet recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • Boston, Massachusetts
  • +2 more
Jul 14, 2022

Ovarian Cancer, Breast Cancer, Folic Acid Deficiency Trial in Chicago (Folic Acid Tablet)

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • Folic Acid Tablet
  • Chicago, Illinois
    Rush University Medical Center
Jul 17, 2022

Ovarian Clear Cell Carcinoma, Gynecologic Cancer Trial in Boston (Lenvatinib, Pembrolizumab)

Recruiting
  • Ovarian Clear Cell Carcinoma
  • Gynecologic Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Oct 13, 2022

Efficacy and Adverse Effects of Olaparib in Ovarian Cancer.

Enrolling by invitation
  • Ovarian Cancer
    • Xi'an, Shaanxi, China
      The First Affliated Hospital of Xi'an Jiaotong University
    Mar 23, 2022

    SCLC,Extensive Stage Trial in Italy (Pembrolizumab/Olaparib)

    Not yet recruiting
    • SCLC,Extensive Stage
    • Meldola, Forlì Cesena, Italy
    • +9 more
    Nov 11, 2022

    Platinum-refractory Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial in Rochester, Helsinki (TILT-123, Pembrolizumab)

    Recruiting
    • Platinum-refractory Ovarian Carcinoma
    • Platinum-resistant Ovarian Cancer
    • TILT-123
    • Pembrolizumab
    • Rochester, Minnesota
    • +1 more
    Aug 12, 2022

    Metastatic Pancreatic Cancer Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Cisplatin)

    Recruiting
    • Metastatic Pancreatic Cancer
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center
    Mar 14, 2022

    Recurrent Ovarian High Grade Serous Adenocarcinoma, Recurrent Platinum-Resistant Ovarian Carcinoma Trial in United States

    Suspended
    • Recurrent Ovarian High Grade Serous Adenocarcinoma
    • Recurrent Platinum-Resistant Ovarian Carcinoma
    • Phoenix, Arizona
    • +8 more
    Jul 26, 2022

    Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemo, Platinum Sensitive Trial in China,

    Active, not recruiting
    • Relapsed Ovarian Cancer
    • +2 more
    • Olaparib 300mg tablets
    • Beijing, China
    • +24 more
    Dec 5, 2022

    High Grade Serous Carcinoma Trial in Baltimore, Boston, Philadelphia (Olaparib Pill, AZD6738)

    Recruiting
    • High Grade Serous Carcinoma
    • Baltimore, Maryland
    • +2 more
    Mar 4, 2022

    BRCA-Mutated Ovarian Carcinoma, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston (Chemotherapy, Olaparib, Therapeutic

    Recruiting
    • BRCA-Mutated Ovarian Carcinoma
    • +30 more
    • Houston, Texas
      M D Anderson Cancer Center
    May 27, 2022

    Epithelial Ovarian Cancer Trial in Mannheim, Essen, Hamburg (olaparib, durvalumab)

    Recruiting
    • Epithelial Ovarian Cancer
    • Mannheim, Baden-Württemberg, Germany
    • +2 more
    Jun 15, 2022

    Ovarian Cancer Trial in Worldwide (Olaparib, Cediranib)

    Recruiting
    • Ovarian Cancer
    • Sydney, New South Wales, Australia
    • +53 more
    Sep 26, 2022

    Ovarian Cancer Trial in Manchester (Olaparib, Cediranib, Platinum-based Chemotherapy)

    Completed
    • Ovarian Cancer
    • Manchester, United Kingdom
      The Christie NHS Foundation Trust
    Feb 4, 2022

    Platinum-Refractory Fallopian Tube Carcinoma, Platinum-Refractory Ovarian Carcinoma, Platinum-Refractory Primary Peritoneal

    Recruiting
    • Platinum-Refractory Fallopian Tube Carcinoma
    • +11 more
    • Copanlisib Hydrochloride
    • +4 more
    • Aurora, Colorado
    • +2 more
    Dec 8, 2022

    Ovarian Cancer Trial in Naples (Olaparib, Chemotherapy drug)

    Recruiting
    • Ovarian Cancer
    • Naples, Italy
      IRCCS Istituto Nazionale Tumori di Napoli
    Feb 24, 2022

    Pancreatic Cancer Trial (Pembrolizumab, Olaparib)

    Not yet recruiting
    • Pancreatic Cancer
    • (no location specified)
    Oct 21, 2021

    Endometrial Carcinosarcoma Trial in United States (Pembrolizumab, Olaparib)

    Recruiting
    • Endometrial Carcinosarcoma
    • Basking Ridge, New Jersey
    • +6 more
    Mar 17, 2022

    Metastatic Colorectal Cancer Trial in Spain (Olaparib, Pembrolizumab)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • Sevilla, Andalucia, Spain
    • +14 more
    Aug 2, 2022

    Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

    Active, not recruiting
    • Stage III Fallopian Tube Cancer AJCC v7
    • +14 more
    • Houston, Texas
    • +4 more
    Oct 20, 2022

    Ovarian Cancer Trial in United Kingdom (Olaparib, Cediranib, Paclitaxel)

    Active, not recruiting
    • Ovarian Cancer
    • Belfast, County Antrim, United Kingdom
    • +13 more
    Feb 22, 2022

    Small Cell Carcinoma, Hypercalcaemic Type, Ovarian Cancer Trial in Toronto (Pembrolizumab)

    Active, not recruiting
    • Small Cell Carcinoma, Hypercalcaemic Type
    • Ovarian Cancer
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jan 8, 2023

    High Grade Fallopian Tube Serous Adenocarcinoma, High Grade Ovarian Serous Adenocarcinoma, Peritoneal High Grade Serous

    Recruiting
    • High Grade Fallopian Tube Serous Adenocarcinoma
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 9, 2022

    Fallopian Tube Carcinosarcoma, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial in Buffalo

    Not yet recruiting
    • Fallopian Tube Carcinosarcoma
    • +10 more
    • Bevacizumab
    • +4 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Dec 29, 2022